Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4758-4764

  Pan, Yu ^a   Li, Rui ^a   Meng, Jun Ling ^a   Mao, He Ting ^a   Zhang, Yu ^a   Zhang, Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA INTERFERON; INTERFERON; RETINOIC ACID INDUCIBLE PROTEIN I; SMAD UBIQUITIN REGULATORY FACTOR 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VISA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DEAD-BOX RNA HELICASES; HELA CELLS; HUMANS; INTERFERON TYPE I; MICE; PROTEOLYSIS; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84901260895     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302632     Document Type: Article

References (32)

1. Takeuchi, O., and S. Akira. 2007. Recognition of viruses by innate immunity. Immunol. Rev. 220: 214-224.
2. Wilkins, C., and M. Gale, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22: 41-47.
3. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227: 54-65.
4. Kato, H., K. Takahasi, and T. Fujita. 2011. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 243: 91-98.
5. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-b signaling. Mol. Cell 19: 727-740.
6. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kB and IRF 3. Cell 122: 669-682.
7. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
8. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5- mediated type I interferon induction. Nat. Immunol. 6: 981-988.
9. Loo, Y. M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
10. Oshiumi, H., M. Matsumoto, and T. Seya. 2012. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J. Biochem. 151: 5-11.
11. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
12. Metzger, M. B., V. A. Hristova, and A. M. Weissman. 2012. HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125: 531-537.
13. Arimoto, K., H. Takahashi, T. Hishiki, H. Konishi, T. Fujita, and K. Shimotohno. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA 104: 7500-7505.
14. Zhong, B., L. Zhang, C. Lei, Y. Li, A. P. Mao, Y. Yang, Y. Y. Wang, X. L. Zhang, and H. B. Shu. 2009. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30: 397-407.
15. You, F., H. Sun, X. Zhou, W. Sun, S. Liang, Z. Zhai, and Z. Jiang. 2009. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10: 1300-1308.
16. David, D., S. A. Nair, and M. R. Pillai. 2012. Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression. Biochim. Biophys. Acta 1835: 119-128.
17. Inoue, Y., and T. Imamura. 2008. Regulation of TGF-b family signaling by E3 ubiquitin ligases. Cancer Sci. 99: 2107-2112.
18. Kaneki, H., R. Guo, D. Chen, Z. Yao, E. M. Schwarz, Y. E. Zhang, B. F. Boyce, and L. Xing. 2006. Tumor necrosis factor promotes Runx2 degradation through upregulation of Smurf1 and Smurf2 in osteoblasts. J. Biol. Chem. 281: 4326-4333.
19. Schwamborn, J. C., M. Muller, A. H. Becker, and A. W. Puschel. 2007. Ubiquitination of the GTPase Rap1B by the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity. EMBO J. 26: 1410-1422.
20. Fukunaga, E., Y. Inoue, S. Komiya, K. Horiguchi, K. Goto, M. Saitoh, K. Miyazawa, D. Koinuma, A. Hanyu, and T. Imamura. 2008. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. J. Biol. Chem. 283: 35660-35667.
21. Lee, Y. S., J. S. Park, J. H. Kim, S. M. Jung, J. Y. Lee, S. J. Kim, and S. H. Park. 2011. Smad6-specific recruitment of Smurf E3 ligases mediates TGF-b1-induced degradation of MyD88 in TLR4 signalling. Nat. Commun. 2: 460.
22. Smith, M. P., J. Ferguson, I. Arozarena, R. Hayward, R. Marais, A. Chapman, A. Hurlstone, and C. Wellbrock. 2013. Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. J. Natl. Cancer Inst. 105: 33-46.
23. Zhang, J., L. G. Xu, K. J. Han, X.Wei, and H. B. Shu. 2004. PIASy represses TRIFinduced ISRE and NF-kB activation but not apoptosis. FEBS Lett. 570: 97-101.
24. Paz, S., M. Vilasco, M. Arguello, Q. Sun, J. Lacoste, T. L.-A. Nguyen, T. Zhao, E. A. Shestakova, S. Zaari, A. Bibeau-Poirier, et al. 2009. Ubiquitin-regulated recruitment of IkB kinase e to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29: 3401-3412.
25. Zhou, X., F. You, H. Chen, and Z. Jiang. 2012. Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS). Cell Res. 22: 717-727.
26. Castanier, C., N. Zemirli, A. Portier, D. Garcin, N. Bidere, A. Vazquez, and D. Arnoult. 2012. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol. 10:44.
27. Allen, I. C., C. B. Moore, M. Schneider, Y. Lei, B. K. Davis, M. A. Scull, D. Gris, K. E. Roney, A. G. Zimmermann, J. B. Bowzard, et al. 2011. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kB signaling pathways. Immunity 34: 854-865.
28. Yasukawa, K., H. Oshiumi, M. Takeda, N. Ishihara, Y. Yanagi, T. Seya, S.-i. Kawabata, and T. Koshiba. 2009. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci. Signal. 2: ra47.
29. Vitour, D., S. Dabo, M. Ahmadi Pour, M. Vilasco, P.-O. Vidalain, Y. Jacob, M. Mezel-Lemoine, S. Paz, M. Arguello, R. Lin, et al. 2009. Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. J. Biol. Chem. 284: 21797-21809.
30. Zhao, Y., X. Sun, X. Nie, L. Sun, T. S. Tang, D. Chen, and Q. Sun. 2012. COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLoS Pathog. 8: e1003086.
31. Huang, C. 2010. Roles of E3 ubiquitin ligases in cell adhesion and migration. Cell Adhes. Migr. 4: 10-18.
32. Dabydeen, S. A., and P. I. Meneses. 2011. Smurf2 alters BPV1 trafficking and decreases infection. Arch. Virol. 156: 827-838.